Celsis Hosts User Group Meeting for its European Pharmaceutical Customers

Celsis International Ltd. hosted the first user group meeting for customers in the pharmaceutical industry at its offices in Brussels, Belgium. The full-day meeting included presentations from two of Celsis’ pharmaceutical customers, representing Janssen Pharmaceutica and Schering-Plough (Merck), who both discussed and answered questions about their experiences using the Celsis Advance™ system. Attendees also benefited from presentations covering topics from the European Medicines Agency (EMA) validation pathways to available regulatory tools, as well as a scientific presentation on rapid sterility testing using the Celsis AKuScreen™ system. "We presented a case study about our experiences in validating and implementing a rapid microbial method. For the user group, we described the benefits we have received by introducing Celsis Rapid Detection products - specifically in achieving shorter cycle times," said Miek Van Loon, Janssen Pharmaceutica. Dr. Geert Verdonk, of Schering-Plough (Merck) stated that they "discussed and provided information proving that a statistical model is suitable for the implementation and validation of new technologies."